See Also: New York Times Exposes Government Conspiracy to Prevent Medical Marijuana Research
(Source: MyFoxAtlanta) About eight out of 10 Americans favor legalizing marijuana for medicinal use. Fourteen states have now done so. The Obama administration has announced it will not prosecute medical marijuana users.
Yet the federal government is making it exceedingly difficult for research to verify that marijuana is an effective treatment for conditions ranging from glaucoma to multiple sclerosis, reported The New York Times .
Many patients with conditions such as cancer, glaucoma, AIDS or chronic pain swear by marijuana’s effectiveness. It appears at least as safe as many prescription drugs used for similar purposes. Yet there have been few scientific studies on it, and even fewer with conclusive results. Much of the evidence for its validity as a medical treatment is anecdotal.
In the United States, researchers who wish to study the effects of marijuana have only one source for their raw material. It is grown at the University of Mississippi, and its distribution is controlled by multiple federal agencies. To use it, researchers must apply to the National Institute on Drug Abuse, and must get approvals from the DEA, FDA and a special Public Health Service panel.
The majority of research requests are denied by one or more of these agencies. If they are approved, the researchers are limited to the few varieties of marijuana grown by the university. Other varieties have somewhat different medicinal properties, which cannot be studied as long as access to them is denied. The federal government does not make it as difficult to study Ecstasy or LSD.
In 1985, the FDA approved Marinol , a pill made from synthetic THC, an active chemical in marijuana. The agency claimed that it has the same medicinal effects and less risk. Many patients who have taken Marinol, however, say it did not work for them, or gave them more side effects than smoking marijuana.
Deaths from Marijuana v. 17 FDA-Approved Drugs – from ProCon
|
DRUG CLASSIFICATION
|
Specific
Drugs per Category |
Primary
Suspect of the Death |
Secondary Suspect (Contributing to death)
|
Total Deaths Reported
1/1/97 – 6/30/05 |
|
| A. MARIJUANA also known as: Cannabis sativa L |
Marijuana Cannabis Cannabinoids |
0
|
279
|
279
|
|
| B. ANTI-EMETICS (used to treat vomiting) |
196
|
429
|
625
|
||
| C. ANTI-SPASMODICS (used to treat muscle spasms) |
118
|
56
|
174
|
||
| D. ANTI-PSYCHOTICS (used to treat psychosis) |
1,593
|
702
|
2,295
|
||
| E. OTHER POPULAR DRUGS (used to treat various conditions including ADD, depression, narcolepsy, erectile dysfunction, and pain) |
8,101
|
492
|
8,593
|
||
| F. TOTALS of A-E |
Number
of Drugs in Total |
Primary
Suspect of the Death |
Secondary Suspect (Contributing to death)
|
Total Deaths Reported
1/1/97 – 6/30/05 |
|
|
1
|
0
|
279
|
279
|
|
|
17
|
10,008
|
1,679
|
11,687
|
|
V. Chart of Deaths from Marijuana and 17 FDA-Approved Drugs
Sub-Total – Anti-Emetics F. TOTALS of A-E |
Primary Suspect
|
Secondary Suspect (Contributing to death)
|
Total Deaths Reported
1/1/97 – 6/30/05 |
|
|
0
|
279
|
279
|
|
|
10,008
|
1,679
|
11,687
|
|
